$BAYA
Bayview Acquisition Corp

2024 Q4 Form 10-Q Financial Statement

#000149315224046013 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $273.0K $6.930K
YoY Change 3839.81%
Operating Profit -$273.0K -$3.823K
YoY Change 7041.75%
Interest Expense $856.6K
YoY Change
% of Operating Profit
Other Income/Expense, Net $856.6K
YoY Change
Pretax Income $583.6K -$6.930K
YoY Change -8520.78%
Income Tax
% Of Pretax Income
Net Earnings $583.6K -$6.930K
YoY Change -8520.75%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.08 $0.00
COMMON SHARES
Basic Shares Outstanding 5.442M shares 7.733M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $225.5K
Short-Term Investments
Other Short-Term Assets $446.5K
YoY Change
Inventory
Prepaid Expenses $66.82K
Receivables
Other Receivables
Total Short-Term Assets $292.3K $446.5K
YoY Change -34.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $38.75M $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $292.3K $446.5K
Total Long-Term Assets $38.75M $0.00
Total Assets $39.05M $446.5K
YoY Change 8644.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $322.3K
YoY Change
Accrued Expenses $445.5K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $600.5K $428.4K
YoY Change 40.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $600.5K $428.4K
Total Long-Term Liabilities $0.00
Total Liabilities $2.701M $428.4K
YoY Change 530.33%
SHAREHOLDERS EQUITY
Retained Earnings -$2.408M
YoY Change
Common Stock $173.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.408M $18.07K
YoY Change
Total Liabilities & Shareholders Equity $39.05M $446.5K
YoY Change 8644.63%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $583.6K -$6.930K
YoY Change -8520.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$80.00 $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $23.68M
YoY Change
Cash From Investing Activities $23.68M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.68M
YoY Change
NET CHANGE
Cash From Operating Activities -80.00 0.000
Cash From Investing Activities 23.68M
Cash From Financing Activities -23.68M
Net Change In Cash -80.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$80.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001969475
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10170
dei City Area Code
CityAreaCode
(347)
dei Local Phone Number
LocalPhoneNumber
627-0058
CY2024Q3 us-gaap Assets
Assets
39045665 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5441511 shares
CY2024Q3 us-gaap Cash
Cash
225472 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
600523 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2100000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2700523 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
38753371 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
173 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39045665 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
273029 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1888696 usd
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
BAYVIEW ACQUISITION CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
420 Lexington Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2446
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q4 us-gaap Cash
Cash
582308 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
313759 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2100000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2413759 usd
CY2024Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
3709011 shares
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
6000000 shares
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.45
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.02
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
60107055 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1732500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1732500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1957500 shares
CY2024Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
3709011 shares
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
6000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
196 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2408402 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1729956 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2408229 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1729760 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60791054 usd
us-gaap Operating Expenses
OperatingExpenses
553469 usd
us-gaap Operating Expenses
OperatingExpenses
6928 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-273029 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-553469 usd
us-gaap Net Income Loss
NetIncomeLoss
1771223 usd
us-gaap Net Income Loss
NetIncomeLoss
-6928 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
225000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1729760 usd
CY2024Q1 BAYA Stock Issued During Period Value Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
StockIssuedDuringPeriodValueSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-754312 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
595376 usd
CY2024Q2 BAYA Stock Issued During Period Value Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
StockIssuedDuringPeriodValueSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-713793 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
592289 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-2010200 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
225000 shares
us-gaap Net Income Loss
NetIncomeLoss
1771223 usd
us-gaap Net Income Loss
NetIncomeLoss
-6928 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2324692 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
141764 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-34869 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
20000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
6928 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-356836 usd
BAYA Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
23803376 usd
BAYA Principal Deposited Into Trust Account In Connection With Extension
PrincipalDepositedIntoTrustAccountInConnectionWithExtension
125000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23678376 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23803376 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23678376 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-356836 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
582308 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225472 usd
BAYA Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount
2324692 usd
BAYA Deferred Offering Costs Paid By Sponsors In Exchange For Issuance Of Ordinary Shares
DeferredOfferingCostsPaidBySponsorsInExchangeForIssuanceOfOrdinaryShares
25100 usd
BAYA Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
106167 usd
BAYA Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
322266 usd
BAYA Prepaid Expenses Included In Due To Related Party
PrepaidExpensesIncludedInDueToRelatedParty
473 usd
BAYA Percentage Of Outstanding Voting Securities
PercentageOfOutstandingVotingSecurities
1 pure
CY2024Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
125000 usd
CY2024Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
2290989 shares
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.39
CY2024Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23803376 usd
CY2024Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
125000 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
125000 usd
CY2024Q3 us-gaap Cash
Cash
225472 usd
CY2024Q3 BAYA Working Capital
WorkingCapital
308229 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_z3WWG4w0M1ci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225472 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
582308 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
38753371 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
60107055 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
856587 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2324692 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
583558 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3823 usd
us-gaap Net Income Loss
NetIncomeLoss
1771223 usd
us-gaap Net Income Loss
NetIncomeLoss
-6928 usd
CY2024Q3 BAYA Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
856587 usd
BAYA Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
2324692 usd
CY2024Q3 BAYA Accretion Of Temporary Equity Into Redemption Value Extension Deposit
AccretionOfTemporaryEquityIntoRedemptionValueExtensionDeposit
125000 usd
BAYA Accretion Of Temporary Equity Into Redemption Value Extension Deposit
AccretionOfTemporaryEquityIntoRedemptionValueExtensionDeposit
125000 usd
CY2024Q3 BAYA Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
-398029 usd
CY2023Q3 BAYA Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
-3823 usd
BAYA Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
-678469 usd
BAYA Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
-6928 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zKXn61ST4ZG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20240930_z8TncEZce3tf" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
BAYA Stock Issued During Period Value Proceeds From Sales Of Public Units
StockIssuedDuringPeriodValueProceedsFromSalesOfPublicUnits
60000000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
-2460000 usd
BAYA Temporary Equity Offering Costs
TemporaryEquityOfferingCosts
4163327 usd
BAYA Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
6623327 usd
CY2023Q4 BAYA Ordinary Shares Subject To Possible Redemption Excluding Subsequent Measurement
OrdinarySharesSubjectToPossibleRedemptionExcludingSubsequentMeasurement
60000000 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
107055 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
60107055 usd
BAYA Withdrawn In Connection With Redemption
WithdrawnInConnectionWithRedemption
-23803376 usd
BAYA Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Extension Deposit
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionExtensionDeposit
125000 usd
BAYA Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount
2324692 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
38753371 usd
CY2024Q3 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
5250 usd
CY2024Q1 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
5250 usd
CY2024Q2 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
5250 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
15750 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
0 usd
CY2023Q4 BAYA Cash Underwriting Discount Per Unit
CashUnderwritingDiscountPerUnit
0.20
CY2023Q4 BAYA Cash Underwriting Discount
CashUnderwritingDiscount
1200000 usd
CY2023Q4 BAYA Cash Underwriting Discount
CashUnderwritingDiscount
1200000 usd
BAYA Deferred Commission Per Unit
DeferredCommissionPerUnit
0.35
BAYA Deferred Commission
DeferredCommission
2100000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
540000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.50
CY2024Q3 BAYA Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePricePercentage
1.15 pure
CY2024Q3 BAYA Number Of Optionsand Units Shares
NumberOfOptionsandUnitsShares
540000 shares
CY2024Q3 BAYA Number Of Options And Units Ordinary Shares
NumberOfOptionsAndUnitsOrdinaryShares
540000 shares
BAYA Number Of Options And Units Rights To Purchase Ordinary Shares
NumberOfOptionsAndUnitsRightsToPurchaseOrdinaryShares
54000 shares
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
311200 usd
BAYA Business Combination Acquisition Related Costs Incurred
BusinessCombinationAcquisitionRelatedCostsIncurred
311200 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0 usd
BAYA Business Combination Shares Services
BusinessCombinationSharesServices
600000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting and other rights and preferences as may be determined from time to time by the Company’s board of directors.
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
6000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1732500 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1732500 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1957500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1957500 shares
CY2024Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
3709011 shares
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
6000000 shares
BAYA Business Combination Shares Right Description
BusinessCombinationSharesRightDescription
each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
BAYA Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Income Earned On Trust Account
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionIncomeEarnedOnTrustAccount
usd
BAYA Deferred Offering Costs Paid By Sponsors In Exchange For Issuance Of Ordinary Shares
DeferredOfferingCostsPaidBySponsorsInExchangeForIssuanceOfOrdinaryShares
usd
BAYA Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
usd
BAYA Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
usd
BAYA Prepaid Expenses Included In Due To Related Party
PrepaidExpensesIncludedInDueToRelatedParty
usd
CY2023Q3 BAYA Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
usd
BAYA Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
usd
CY2023Q3 BAYA Accretion Of Temporary Equity Into Redemption Value Extension Deposit
AccretionOfTemporaryEquityIntoRedemptionValueExtensionDeposit
usd
BAYA Accretion Of Temporary Equity Into Redemption Value Extension Deposit
AccretionOfTemporaryEquityIntoRedemptionValueExtensionDeposit
usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-41890
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
66822 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
72014 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
292294 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
654322 usd
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
29677 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
38753371 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
60107055 usd
CY2023Q4 us-gaap Assets
Assets
60791054 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
445523 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
303759 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
125000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1957500 shares
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3823 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3823 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6928 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
856587 usd
us-gaap Investment Income Net
InvestmentIncomeNet
2324692 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
856587 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2324692 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
583558 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3823 usd
CY2024Q3 BAYA Stock Issued During Period Value Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
StockIssuedDuringPeriodValueSubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
-856587 usd
CY2024Q3 BAYA Stock Issued During Period Value Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Extension Deposit
StockIssuedDuringPeriodValueSubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionExtensionDeposit
-125000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
583558 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2408229 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25100 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3105 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21995 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21995 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21995 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3823 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3823 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18172 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18172 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
38753371 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
60107055 usd

Files In Submission

Name View Source Status
ex3-1_021.jpg Edgar Link pending
ex3-1_022.jpg Edgar Link pending
ex3-1_023.jpg Edgar Link pending
ex3-1_024.jpg Edgar Link pending
ex3-1_025.jpg Edgar Link pending
ex3-1_026.jpg Edgar Link pending
ex3-1_027.jpg Edgar Link pending
ex3-1_028.jpg Edgar Link pending
ex3-1_029.jpg Edgar Link pending
ex3-1_030.jpg Edgar Link pending
ex3-1_031.jpg Edgar Link pending
ex3-1_032.jpg Edgar Link pending
ex3-1_033.jpg Edgar Link pending
ex3-1_034.jpg Edgar Link pending
ex3-1_035.jpg Edgar Link pending
ex3-1_036.jpg Edgar Link pending
ex3-1_037.jpg Edgar Link pending
ex3-1_038.jpg Edgar Link pending
ex3-1_039.jpg Edgar Link pending
ex3-1_040.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
0001493152-24-046013-index-headers.html Edgar Link pending
0001493152-24-046013-index.html Edgar Link pending
0001493152-24-046013.txt Edgar Link pending
0001493152-24-046013-xbrl.zip Edgar Link pending
baya-20240930.xsd Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex3-1_006.jpg Edgar Link pending
ex3-1_007.jpg Edgar Link pending
ex3-1_008.jpg Edgar Link pending
ex3-1_009.jpg Edgar Link pending
ex3-1_010.jpg Edgar Link pending
ex3-1_011.jpg Edgar Link pending
ex3-1_012.jpg Edgar Link pending
ex3-1_013.jpg Edgar Link pending
ex3-1_014.jpg Edgar Link pending
ex3-1_015.jpg Edgar Link pending
ex3-1_016.jpg Edgar Link pending
ex3-1_017.jpg Edgar Link pending
ex3-1_018.jpg Edgar Link pending
ex3-1_019.jpg Edgar Link pending
ex3-1_020.jpg Edgar Link pending
baya-20240930_def.xml Edgar Link unprocessable
baya-20240930_lab.xml Edgar Link unprocessable
baya-20240930_pre.xml Edgar Link unprocessable
baya-20240930_cal.xml Edgar Link unprocessable